6266-66-6,
2-(1H-Indol-3-yl)-4-oxo-4-phenylbutanoic acid,
2-indol-3-yl-4-oxo-4-phenylbutanoic acid,
PEO-IAA,
2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid,
MLS000716512,
SMR000278029,
2-Inodl-3-yl-4-oxo-4-phenylbutanoic acid,
NSC36840,
Opera_ID_1008,
AC1L5UF8,
AC1Q5F2X,
Oprea1_085797,
Oprea1_800638,
CHEMBL1488848,
SCHEMBL15747704,
CTK5B5513,
DTXSID40284342,
SJVMWLJNHPHNPT-UHFFFAOYSA-N,
HMS1619N05,
HMS2637H09,
HMS3362I06,
KS-000028IC,
MFCD00170195,
NSC-36840,
SBB027977,
STK975951,
AKOS000300600,
AKOS016340265,
CCG-121924,
MCULE-9454584878,
MS-6212,
VZ24786,
BAS 04207246,
ST082318,
HY-112730,
TR-021553,
CS-0062993,
FT-0636051,
Butanoic acid, 4-oxo-2-(3-indolyl)-4-phenyl-,
C-18396,
SR-01000326238,
1H-Indole-3-aceticacid, a-(2-oxo-2-phenylethyl)-,
2-(1H-Indol-3-yl)-4-oxo-4-phenylbutanoic acid #,
I04-3497,
SR-01000326238-1,
1H-Indole-3-aceticacid, |A-(2-oxo-2-phenylethyl)-,
2-indol-3-yl-4-oxo-4-phenylbutanoic acid, AldrichCPR,
1H-Indole-3-acetic acid, .alpha.-(2-oxo-2-phenylethyl)-,
PEO-IAA (Synonyms: 2-(1H-Indol-3-yl)-4-oxo-4-phenyl-butyric acid),
AR-1E2812,
CID235453,
2-INDOL-3-YL-4-OXO-4-PHENYLBUTANOICACID,
6726-65-4,